FdaApplication
ANDA 079135
Identifiers
- fda_app_no: ANDA079135
Properties
| Property | Value |
|---|---|
| applicant_name | GLENMARK PHARMACEUTICALS LTD |
| application_type | ANDA |
| approval_date | 2010-05-05 |
Products (4)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| TRANDOLAPRIL AND VERAPAMIL HYDROCHLORIDE | TRANDOLAPRIL; VERAPAMIL HYDROCHLORIDE | 2MG;240MG | TABLET, EXTENDED RELEASE;ORAL |
| TRANDOLAPRIL AND VERAPAMIL HYDROCHLORIDE | TRANDOLAPRIL; VERAPAMIL HYDROCHLORIDE | 4MG;240MG | TABLET, EXTENDED RELEASE;ORAL |
| TRANDOLAPRIL AND VERAPAMIL HYDROCHLORIDE | TRANDOLAPRIL; VERAPAMIL HYDROCHLORIDE | 1MG;240MG | TABLET, EXTENDED RELEASE;ORAL |
| TRANDOLAPRIL AND VERAPAMIL HYDROCHLORIDE | TRANDOLAPRIL; VERAPAMIL HYDROCHLORIDE | 2MG;180MG | TABLET, EXTENDED RELEASE;ORAL |
4 products